---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-022184"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:48:03.369660+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TRxADE Health signs binding LOI to acquire Superlatus, pivoting to food technology

## Summary
- Superlatus shareholders receive 30,821,918 MEDS shares valued at $7.30 per share, comprising 19.99% of post-merger common stock and remainder in non-voting preferred.
- Merger conditions include Superlatus acquiring Sapientia and Prestige Farms; combined valuation target of at least $225M.
- TRxADE plans to divest its existing pharmaceutical exchange business after closing.
- Expected close in late Q3 or early Q4 2023, subject to due diligence, audited financials, Nasdaq approval.
- Board of both companies unanimously approved LOI.

## SEC filing metadata
- accession: 0001493152-23-022184
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-022184
- JSON: https://secwatch.observer/filing/0001493152-23-022184.json
- Plain text: https://secwatch.observer/filing/0001493152-23-022184.txt

## Key facts
- Material Agreements
  Scienture Holdings, Inc. entered into LOI with Superlatus, Inc. (effective 2023-06-22).
  - Action: entry
  - Agreement: merger
  - Counterparty: Superlatus, Inc.
  - Effective: 2023-06-22
  source text: On June 22, 2023, TRxADE HEALTH, INC. (the "Company") entered into a binding letter of intent ("LOI") for a merger (the "Merger") with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities ("Superlatus").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.